Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Common Equity (2016 - 2025)

Amphastar Pharmaceuticals has reported Common Equity over the past 13 years, most recently at $788.8 million for Q4 2025.

  • Quarterly results put Common Equity at $788.8 million for Q4 2025, up 7.72% from a year ago — trailing twelve months through Dec 2025 was $788.8 million (up 7.72% YoY), and the annual figure for FY2025 was $788.8 million, up 7.72%.
  • Common Equity for Q4 2025 was $788.8 million at Amphastar Pharmaceuticals, up from $776.7 million in the prior quarter.
  • Over the last five years, Common Equity for AMPH hit a ceiling of $788.8 million in Q4 2025 and a floor of $430.2 million in Q3 2021.
  • Median Common Equity over the past 5 years was $592.2 million (2023), compared with a mean of $604.9 million.
  • Biggest five-year swings in Common Equity: fell 4.61% in 2021 and later grew 22.56% in 2024.
  • Amphastar Pharmaceuticals' Common Equity stood at $445.5 million in 2021, then increased by 18.66% to $528.7 million in 2022, then grew by 20.95% to $639.4 million in 2023, then increased by 14.53% to $732.3 million in 2024, then grew by 7.72% to $788.8 million in 2025.
  • The last three reported values for Common Equity were $788.8 million (Q4 2025), $776.7 million (Q3 2025), and $757.5 million (Q2 2025) per Business Quant data.